195 related articles for article (PubMed ID: 32586370)
1. IgG anti-hinge antibodies against IgG4 F(ab')
Ota T; Ota SI; Uchino A; Nagano S
Arthritis Res Ther; 2020 Jun; 22(1):161. PubMed ID: 32586370
[TBL] [Abstract][Full Text] [Related]
2. Anti-Hinge Antibodies Recognize IgG Subclass- and Protease-Restricted Neoepitopes.
Falkenburg WJ; van Schaardenburg D; Ooijevaar-de Heer P; Tsang-A-Sjoe MW; Bultink IE; Voskuyl AE; Bentlage AE; Vidarsson G; Wolbink G; Rispens T
J Immunol; 2017 Jan; 198(1):82-93. PubMed ID: 27864476
[TBL] [Abstract][Full Text] [Related]
3. A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.
Brezski RJ; Kinder M; Grugan KD; Soring KL; Carton J; Greenplate AR; Petley T; Capaldi D; Brosnan K; Emmell E; Watson S; Jordan RE
MAbs; 2014; 6(5):1265-73. PubMed ID: 25517311
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to IgG4 hinge can be found in rheumatoid arthritis patients during all stages of disease and may exacerbate chronic antibody-mediated inflammation.
van de Stadt LA; de Vrieze H; Derksen NI; Brouwer M; Wouters D; van Schaardenburg D; Wolbink G; Rispens T
Arthritis Rheumatol; 2014 May; 66(5):1133-40. PubMed ID: 24782178
[TBL] [Abstract][Full Text] [Related]
5. Elevated Fab glycosylation of anti-hinge antibodies.
Koers J; Derksen N; Falkenburg W; Ooijevaar-de Heer P; Nurmohamed MT; Wolbink GJ; Rispens T
Scand J Rheumatol; 2023 Jan; 52(1):25-32. PubMed ID: 34726124
[TBL] [Abstract][Full Text] [Related]
6. Evading pre-existing anti-hinge antibody binding by hinge engineering.
Kim HS; Kim I; Zheng L; Vernes JM; Meng YG; Spiess C
MAbs; 2016; 8(8):1536-1547. PubMed ID: 27606571
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of human anti-hinge antibodies derived from single-cell cloning of normal human B cells.
Huang T; Mathieu M; Lee S; Wang X; Kee YS; Bevers JJ; Ciferri C; Estavez A; Wong M; Chiang NY; Nakamura G; Brezski RJ
J Biol Chem; 2018 Jan; 293(3):906-919. PubMed ID: 29191832
[TBL] [Abstract][Full Text] [Related]
8. The antigen binding domain of non-idiotypic human anti-F(ab')2 autoantibodies: study of their interaction with IgG hinge region epitopes.
Welschof M; Reineke U; Kleist C; Kipriyanov S; Little M; Volkmer-Engert R; Schneider-Mergener J; Opelz G; Terness P
Hum Immunol; 1999 Apr; 60(4):282-90. PubMed ID: 10363719
[TBL] [Abstract][Full Text] [Related]
9. The natural human IgG anti-F(ab')2 antibody recognizes a conformational IgG1 hinge epitope.
Terness P; Kohl I; Hübener G; Battistutta R; Moroder L; Welschof M; Dufter C; Finger M; Hain C; Jung M
J Immunol; 1995 Jun; 154(12):6446-52. PubMed ID: 7539020
[TBL] [Abstract][Full Text] [Related]
10. [IgM Antibody against IgG Antibody Binding to Antigen, So-Called Anti-Antibody, Reacts Mainly with F (ab')₂ Fragment Possessing Antibody Activity].
Matsuura T; Imamura A; Ota T
Rinsho Byori; 2017 Jan; 65(1):13-18. PubMed ID: 30695506
[TBL] [Abstract][Full Text] [Related]
11. Interaction of the hinge region of human immunoglobulin G with a murine lymphocyte membrane receptor. Relevance to the problem of antiglobulin induction in rheumatoid arthritis.
Johnson PM; Papamichail M; Gutierrez C; Holborow EJ
Immunology; 1975 May; 28(5):797-805. PubMed ID: 48497
[TBL] [Abstract][Full Text] [Related]
12. Anti-Fab antibodies in humans. Predominance of minor immunoglobulin G subclasses in rheumatoid arthritis.
Persselin JE; Stevens RH
J Clin Invest; 1985 Aug; 76(2):723-30. PubMed ID: 3928684
[TBL] [Abstract][Full Text] [Related]
13. Proteolysis of purified IgGs by human and bacterial enzymes in vitro and the detection of specific proteolytic fragments of endogenous IgG in rheumatoid synovial fluid.
Ryan MH; Petrone D; Nemeth JF; Barnathan E; Björck L; Jordan RE
Mol Immunol; 2008 Apr; 45(7):1837-46. PubMed ID: 18157932
[TBL] [Abstract][Full Text] [Related]
14. The specificity of antibodies to the F(ab')2 fragment of human IgG.
Heimer R; Wolfe LD; Abruzzo JL
Arthritis Rheum; 1985 May; 28(5):562-8. PubMed ID: 3873943
[TBL] [Abstract][Full Text] [Related]
15. Levels and in vitro functional effects of circulating anti-hinge antibodies in melanoma patients receiving the immune checkpoint inhibitor pembrolizumab.
Hock BD; Goddard L; MacPherson SA; Strother M; Gibbs D; Pearson JF; McKenzie JL
PLoS One; 2023; 18(9):e0290793. PubMed ID: 37713423
[TBL] [Abstract][Full Text] [Related]
16. Proton nuclear magnetic resonance studies of human immunoglobulins: conformation of the hinge region of the IgG1 immunoglobulin.
Arata Y; Honzawa M; Shimizu A
Biochemistry; 1980 Oct; 19(22):5130-5. PubMed ID: 6257277
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin (Ig)G1 and IgG4 anti-cyclic citrullinated peptide (CCP) associate with shared epitope, whereas IgG2 anti-CCP associates with smoking in patients with recent-onset rheumatoid arthritis (the Swedish TIRA project).
Martinsson K; Johansson A; Kastbom A; Skogh T
Clin Exp Immunol; 2017 Apr; 188(1):53-62. PubMed ID: 27859022
[TBL] [Abstract][Full Text] [Related]
18. A natural IgA-anti-F(ab')2gamma autoantibody occurring in healthy individuals and kidney graft recipients recognizes an IgG1 hinge region epitope.
Terness P; Navolan D; Moroder L; Siedler F; Weyher E; Kohl I; Dufter C; Welschof M; Drugarin D; Schneider F; Opelz G
J Immunol; 1996 Nov; 157(9):4251-7. PubMed ID: 8892664
[TBL] [Abstract][Full Text] [Related]
19. Human IgG anti-F(ab')2 antibodies possess rheumatoid factor activity.
Hunt Gerardo S; Persselin JE; Stevens RH
Clin Exp Immunol; 1990 Aug; 81(2):293-300. PubMed ID: 1696866
[TBL] [Abstract][Full Text] [Related]
20. Use of monoclonal antibodies and F(ab')2 enzyme conjugates in ELISA for IgM, IgA and IgG rheumatoid factors.
Teitsson I; Valdimarsson H
J Immunol Methods; 1984 Jul; 71(2):149-61. PubMed ID: 6376635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
